Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve the financial results for the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Godavari Drugs Ltd has informed BSE that its Board of Directors meeting is scheduled for May 27, 2026 to consider and approve the Audited Standalone Financial Results for the quarter and Financial Year ended March 31, 2026. The filing is made under SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The company has also confirmed that the trading window for insiders was closed from April 1, 2026 and will reopen 48 hours after the declaration of results. This is a standard regulatory intimation and does not contain any actual financial figures or results at this stage.
This is a routine pre-result announcement and does not directly impact shareholders at this stage. Actual financial results will be disclosed after the May 27, 2026 board meeting, which could trigger stock price movement depending on whether the results meet market expectations.